| Revenue growth | Not disclosed; brand-level growth only |
|---|---|
| Margins | Max Protein EBITDA expanded; no group margins |
| Demand visibility | Resilient demand; urban recovery, rural offtake improving |
| Management confidence | Upbeat; claims outperforming internal projections |
Growth
Qualitative only: Glucon-D strong growth on low base; Sugar Free, Nutralite, Complan double-digit; I'm Lite high single-digit YTD.
Outlook
No explicit guidance. Pipeline: Monk fruit sweetener, Max Protein Crunchy Cookies, Glucon-D ORS, Cuticolor Bright Brown.
Risks
Input cost inflation (crude derivatives, edible oils, packaging, milk); geopolitical disruption affecting international business.
Last quarter's promises, checked
Delivered
- Core brands double-digit ex-summer → Nutralite, Sugar Free, Complan, Everyuth double-digit (= BEAT)
Partly delivered
- Max Protein 'maintain growth momentum' → EBITDA expanded; growth rate undisclosed (= PARTIAL)
Missed
- I'm Lite 'higher double-digit' → high single-digit YTD (= MISS)
Investor Presentation filed with NSE, NSE: ZYDUSWELL. Summary written with AI assistance from the document.
Zydus Wellness Ltd: key numbers
- Share price
- ₹498.65
- Market cap
- ₹15,865 Cr
- Revenue (annual)
- ₹3,961 Cr
- Net profit (annual)
- ₹197.2 Cr
- P/E (TTM)
- 84.3×Sector 38.8×
- Promoter holding
- 69.64%+0.00% QoQ
- FII holding
- 3.57%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zydus Wellness Ltd
All →Zydus Wellness Results Update
Zydus Wellness reported Q2 FY27 consolidated net sales of ₹11,227 million, up 74.6% YoY. EBITDA grew 271.7% to ₹855 million on strong brand momentum.
Zydus Wellness Q2 FY27 Results: Turns Profitable, Net Profit ₹5.1 Cr
Zydus Wellness Ltd reported revenue from operations of ₹1,127 Cr (+73.2% YoY) and net profit of ₹5.1 Cr for Q2 FY27.
- Key figure
- Net profit ₹5.1 Cr
Zydus Wellness Price Movement Clarification
Zydus Wellness clarified that it received a notice from FSSAI regarding alleged misleading product claims. The company stated that its labels are factual and supported by scientific substantiation.
Zydus Wellness Other Announcement
Zydus Wellness Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Zydus Wellness Management Change
Zydus Wellness Limited announced the resignation of Mr. Arijit Sengupta, Chief Marketing Officer, effective September 18, 2026.
Zydus Wellness Price Movement Clarification
Zydus Wellness clarified to NSE that the spurt in volume is purely market-driven with no undisclosed information. The company confirmed all Reg 30 disclosures have been made.